Perimenopausal Anxiety: The Why and How
By Shannon Parks DO, DABPN
Perimenopausal Anxiety: Why It Happens and Evidence-Based Ways to Find Relief
Many women are surprised when anxiety begins to appear in their late 30s or 40s—especially if they have never struggled with it before. Heart racing, sudden worry, disrupted sleep, irritability, and even panic attacks can emerge seemingly out of nowhere.
For many patients, these symptoms coincide with perimenopause, the hormonal transition leading up to menopause. During this stage, fluctuating estrogen and progesterone levels can significantly affect the brain systems that regulate mood and stress.
Understanding the connection between hormones and mental health can be an important first step in finding relief.
The Hormone–Mood Connection
Perimenopause is characterized by irregular fluctuations in estrogen and progesterone, hormones that interact closely with neurotransmitters involved in mood regulation, including serotonin, dopamine, and GABA.
Research suggests that these hormonal shifts can increase vulnerability to anxiety and mood disturbances, particularly in women with prior sensitivity to hormonal changes such as premenstrual mood symptoms or postpartum depression.
Studies have shown that women in the menopausal transition are two to four times more likely to experience clinically significant depressive and anxiety symptoms compared to premenopausal women.¹
In addition to hormonal changes, other midlife stressors—including career demands, caregiving responsibilities, and sleep disruption—may further contribute to emotional distress.
Common Symptoms of Perimenopausal Anxiety
Perimenopausal anxiety can manifest in several ways, including:
Persistent or excessive worry
Panic attacks or sudden waves of fear
Heart palpitations or chest tightness
Irritability and emotional sensitivity
Difficulty concentrating
Insomnia or disrupted sleep
Physical tension or restlessness
These symptoms may occur independently or alongside other menopausal symptoms such as hot flashes, night sweats, and fatigue.
Evidence-Based Strategies for Managing Perimenopause Anxiety
Fortunately, there are several evidence-based approaches that can help regulate the nervous system and reduce anxiety symptoms during this transitional period.
Cognitive Behavioral Therapy (CBT)
Cognitive Behavioral Therapy is one of the most extensively researched treatments for anxiety disorders. CBT helps individuals identify unhelpful thought patterns and develop healthier cognitive responses to stress.
Research published in Menopause and JAMA Psychiatry has shown that CBT can significantly improve mood, anxiety symptoms, and sleep quality in women experiencing menopausal symptoms.²
Lifestyle Interventions
Certain lifestyle habits can also play a meaningful role in stabilizing mood during perimenopause.
Regular aerobic exercise has been shown to reduce anxiety and improve emotional resilience through regulation of stress hormones and neurotransmitters.³
Sleep hygiene is equally important, as hormonal changes during perimenopause often disrupt sleep patterns, which can worsen anxiety.
Helpful strategies include:
Maintaining a consistent sleep schedule
Limiting caffeine and alcohol intake
Practicing relaxation techniques before bed
Incorporating regular physical activity
Mindfulness-based stress reduction programs have also demonstrated measurable improvements in anxiety and stress among midlife women.⁴
Psychiatric Medications for Perimenopausal Anxiety
In some cases, psychiatric medications can play an important role in treating moderate to severe perimenopausal anxiety, particularly when symptoms significantly interfere with daily functioning.
Selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) are among the most commonly studied and prescribed medications for anxiety disorders during the menopausal transition. These medications regulate serotonin and norepinephrine pathways that influence mood, emotional regulation, and the body's stress response.⁵
Several clinical studies have demonstrated that SSRIs and SNRIs may improve both anxiety symptoms and vasomotor symptoms such as hot flashes, which can further support improvements in sleep and overall emotional stability.⁶
Psychiatric medications are typically considered when symptoms are persistent, when psychotherapy alone is insufficient, or when anxiety occurs alongside depressive symptoms. Treatment decisions are individualized and may include careful monitoring of medication response, hormone status, and other medical factors affecting mood regulation.⁷
When prescribed thoughtfully and combined with lifestyle interventions and psychotherapy, psychiatric medications can be a safe and effective component of a comprehensive treatment plan for perimenopause-related anxiety.
A Comprehensive Approach to Women's Mental Health
Perimenopause is a complex biological transition that can significantly influence emotional well-being. For many women, recognizing that anxiety may have a hormonal component can be both validating and empowering.
A comprehensive treatment approach often includes a combination of:
psychotherapy
lifestyle and sleep optimization
medication management when appropriate
collaborative care with other women's health providers
With the right support, most women can navigate this stage with greater stability, clarity, and resilience.
References (Peer-Reviewed Medical Literature)
Freeman MP, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry. 2006;63(4):375–382.
Hunter MS, Smith M. Managing hot flushes and night sweats: a cognitive behavioural approach to menopause. Menopause. 2014.
Herring MP, O’Connor PJ, Dishman RK. The effect of exercise training on anxiety symptoms among patients. Archives of Internal Medicine. 2010.
Carmody J et al. Mindfulness-based stress reduction for menopausal symptoms. Menopause. 2011.
Soares CN. Mood disorders in midlife women: understanding the critical window and the role of hormonal fluctuations. Menopause. 2014.
Loprinzi CL et al. Phase III comparison of venlafaxine for the management of hot flashes. Journal of Clinical Oncology. 2000.
Clayton AH, Ninan PT. Depression or menopause? Presentation and management of major depressive disorder in perimenopausal women. Primary Care Companion to the Journal of Clinical Psychiatry. 2010.
About the Author
Shannon Parks, DO, is a Diplomate of the American Board of Psychiatry and Neurology and Founder and Medical Director of The Parks Center for Women’s Wellness and Medicine in Tinton Falls, NJ. She is recognized for delivering elevated, root-cause–driven integrative psychiatric care and for advancing comprehensive mental health treatment for women.
